Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms

Abstract

The observed radioresistance of human glioblastoma multiforme (GBM) poses a major challenge, which, if overcome, may lead to significant advances in the management of this patient population. There is accumulating evidence from correlative studies that Survivin expression is associated with increased malignant potential of human gliomas. The purpose of this study was to investigate whether Survivin plays a direct role in mediating radiation resistance in primary human glioma cell lines, and, if so, investigating the underlying mechanisms. Our panel of GBM cell lines included two that were relatively radiation resistant (GM20 and GM21) and two that were more radiation sensitive (GM22 and GM23), which demonstrated differential levels of Survivin expression between the two groups. Through the use of adenoviral vectors containing either dominant-negative (pAd-S(T34A)) or wild-type Suvrivin (pAd-S(WT)), we were able to inactivate or overexpress Survivin, respectively. Our findings suggest that Survivin plays a critical role in mediating radiation resistance in primary GBM cells, in part through suppression of apoptotic cell death via a caspase-independent manner. We have identified novel mechanisms by which Survivin may enhance tumor cell survival upon radiation exposure such as regulation of double-strand DNA break repair and tumor cell metabolism, which were most evident in the radiation-resistant cell lines. These differences in Survivin function both in radiation-resistant vs radiation-sensitive cell lines and in the presence vs absence of radiation exposure warrant further investigation and highlight potentially important mechanisms of radiation resistance in these tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adida C, Berrebi D, Peuchmaur M and Al E . (1998). Lancet, 351, 882–883.

  • Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC and Molina TJ . (2000). Blood, 96, 1921–1925.

  • Altieri DC . (2003). Oncogene, 22, 8581–8589.

  • Ambrosini G, Adida C and Altieri DC . (1997). Nat. Med., 3, 917–921.

  • Ambrosini G, Adida C, Sirugo G and Altieri DC . (1998). J. Biol. Chem., 273, 11177–11182.

  • Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi H and Watanabe N . (2000). Jpn. J. Cancer Res., 91, 1204–1209.

  • Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N and Kroemer G . (2002). Biochimie, 84, 215–222.

  • Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ and Loeffler JS . (2002). J. Clin. Oncol., 20, 1063–1068.

  • Conway EM, Pollefeyt S, Cornelissen J, DeBacre I, Steiner-Mosonyi M, Ong K, Baens M, Colien D and Schuh AC . (2000). Blood, 95, 1435–1442.

  • Davis FG, McCarthy BJ, Freels S and Al E . (1999). Cancer, 85, 485–491.

  • Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchiso PC and Altieri DC . (2002a). J. Cell Sci., 115, 575–585.

  • Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC and Altieri DC . (2002b). J. Cell Sci., 115 (Part 3), 575–585.

  • Grossman D, Kim PJ, Schechner JS and Altieri DC . (2001). Proc Natl Acad Sci USA, 98, 635–640.

  • Hall EJ . (2000). Radiobiology for the Radiologist 5th edn. Lippincott Williams & Wilkins: Philadelphia.

    Google Scholar 

  • Islam A, Kageyama H, Takada N, Kawamato T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y and Nakagawara A . (2000). Oncogene, 19, 617–623.

  • Jiang X, Wilford C, Duensing S, Munger K, Jones G and Jones D . (2001). J. Cell Biochem., 83, 342–354.

  • Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita N and Kurisu K . (2003). Cancer, 97, 1077–1083.

  • Katoh M, Wilmonte R, Belkouch M-C, de Tribolet N, Pizzolato G and Dietrich P-Y . (2003). J. Neurooncol., 64, 71–76.

  • Kawasaki H, Altieri DC, Lu CD and Al E . (1998). Cancer Res., 58, 5071–5074.

  • Kobayashi K, Hatano M, Otaki M, Ogasawara T and Tokuhisa T . (1999). Proc. Nat. Acad. Sci. USA, 96, 1457–1462.

  • Lang-Rollin I, Rideout H, Noticewala M and Stefanis L . (2003). J. Neuorosci., 23, 11015–11025.

  • Li F and Altieri DC . (1999). Biochem. J., 344, 305–311.

  • Lu CD, Altieri DC and Tanigawa N . (1998). Cancer Res., 58, 1808–1812.

  • Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA . (2001). Genes Dev., 15, 1311–1333.

  • Mangiardi J . (2001). Brain Tumors Kaye A, Laws E (eds). Churchill Livingston: New York City, pp. 105–117.

    Google Scholar 

  • Merlo A . (2003). Neurosurg. Rev., 26, 145–158.

  • Mesri M, Wall NR, Li J, Kim RW and Altieri DC . (2001). J. Clin. Invest., 108, 981–990.

  • Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A and Abad A . (1999). J. Clin. Oncol., 17, 2100–2104.

  • Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA and Zangemeister-Wittke U . (2000). Cancer Res., 60, 2805–2809.

  • Sasaki T, Lopes MB, Hankins GR and Helm GA . (2002). Acta. Neuropathol, 104, 105–109.

  • Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK and Oh BH . (2001). Biochemistry, 40, 1117–1123.

  • Skoufias DA, Mollinari C, Lacroix FB and Margolis RL . (2000). J. Cell Biol., 151, 1575–1582.

  • Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM and Altieri DC . (2001). JAMA, 285, 324–328.

  • Tan EC, Leung T, Manser E and Lim L . (1993). J. Biol. Chem., 268, 27291–27298.

  • Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N . (2000). Clin. Cancer Res., 6, 127–134.

  • Walker MD, Alexander E and Hunt WE . (1978). J. Neurosurg., 49, 333–343.

  • Walker MD, Green SB and Byar DP . (1980). N. Engl. J. Med., 303, 1323–1329.

  • Westphal M, Hansel M, Nausch H, Rohde E and Hermann HD . (1990). Culture of Human Brain Tumors on an Extracellular Matrix Derived from Bovine Corneal Endothelial Cells and Cultured Human Glioma Cells, Vol 5. Humana Press: Clifton, NJ.

    Book  Google Scholar 

  • Wright ME, Han DK and Hockenbery DM . (2000). FEBS Lett., 481, 13–18.

Download references

Acknowledgements

We acknowledge the kind generosity of Dr Dario Altieri (University of Massachusetts Medical Center) for providing the following adenoviral constructs: pAd-S(T34A) and pAd-S(WT). This work was supported by grants NIH KO882163CA, Massachusetts General Hospital Brian D Silber Memorial Fund, Goldhirsh Brain Tumor Award (all to AC)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnab Chakravarti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakravarti, A., Zhai, G., Zhang, M. et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23, 7494–7506 (2004). https://doi.org/10.1038/sj.onc.1208049

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208049

Keywords

This article is cited by

Search

Quick links